Medical Aesthetics Market Key Highlights and Future Opportunities Till 2035
Given the vast potential of medical aesthetic solutions, several investors have extended financial support. During our research, we came across 50 funding instances focused on medical aesthetics, during the period 2018-2023, which amounted to a total of more than USD 3.6 billion.
The global medical aesthetics market size is estimated to grow from USD 38 billion in 2024 to USD 102 billion by 2035, representing a CAGR of 9.5% during the forecast period till 2035.
The maximum number of funding instances focused on medical aesthetics were reported in 2021, this can be attributed to the impact of COVID-19 pandemic. During the pandemic, people became more conscious of their outer appearance (popularly termed as “Zoom Effect”) which led to an increased interest in medical aesthetic procedures. This increased demand of medical aesthetic procedures is indicative of the future potential of medical aesthetic solutions resulting in increased funding activity which is likely to help propel the growth of this industry.
Companies engaged in the medical aesthetics domain have raised a significant amount of capital through venture capital rounds (24%). It is worth highlighting that a number of players in this domain have managed to secure significant capital through debt as well.
The maximum number of funding instances (64%) were reported by companies based in North America, raising more than 50% of the total amount during the given time period. This is followed by companies based in Europe, raising over 30% of the total invested amount. Further, in the Asia-Pacific region constitutes 19% of the total amount invested across nine funding rounds.
Several leading players engaged in this domain are performing well under the influence of both external and internal factors.
DELT analysis is a framework that is used to assess the environment in which a company operates / intends to enter. The analysis is used to review strategic planning processes, which can aid the organization in mitigating upcoming risks. In addition, the analysis can be deployed to invent strategies that can influence financing decisions in order to increase profitability. This chapter presents a detailed DELT analysis (in terms of the impact of external and internal factors) of the leading medical aesthetic companies using spider web representations. It also features a conclusion, which has been presented in the form of a 2*2 grid, with impact of internal factors on the abscissa and impact of external factors on the ordinate.
With the growing focus on improving outer appearance, the medical aesthetics market is expected to grow at a steady pace. The medical aesthetics market is experiencing significant growth and is expected to continue to grow at a CAGR of 9.3% during the time period, 2023-2035. This presents an opportunity for medical aesthetic companies to maximize their gains by distributing / supplying and licensing their products and / or devices.
The estimated market opportunity is projected to be well distributed across different end-users, gender, distribution channels and key geographical regions. Breast Implants procedures are one of the most potential revenue generators in the medical aesthetics market. The breast implants market is experiencing significant growth and is expected to continue to grow at a CAGR of around 9.4% during the time period, 2023-2035. This presents an opportunity for medical aesthetic companies to maximize their gains by distributing / supplying and licensing their products.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/medical-aest
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/
